{
  "actions": [
    {
      "acted_at": "1995-07-19T12:48:00-04:00", 
      "references": [], 
      "text": "Amendment (A003) offered by Mr. Duncan.", 
      "type": "action"
    }, 
    {
      "acted_at": "1995-07-19T14:10:00-04:00", 
      "how": "roll", 
      "references": [], 
      "result": "pass", 
      "roll": 528, 
      "text": "On agreeing to the Duncan amendment (A003) Agreed to by recorded vote: 278 - 146 (Roll no. 528).", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "h"
    }
  ], 
  "amendment_id": "hamdt567-104", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr2020-104", 
    "bill_type": "hr", 
    "congress": 104, 
    "number": 2020
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "104", 
  "description": "Amendment deletes $65.76 million appropriated for the Food and Drug Administration Phase II project in Maryland.", 
  "house_number": 3, 
  "introduced_at": "1995-07-19", 
  "number": 567, 
  "purpose": "An amendment, not preprinted in the Congressional Record, to reduce by $65.7 million in funds appropriated in the bill for the GSA Federal Buildings Fund for construction of additional projects. The intent of the amendment would be, in part, to cancel new construction for \"FDA Phase II\" in Montgomery and Prince George's counties in Maryland.", 
  "sponsor": {
    "district": "2", 
    "name": "Duncan, John J., Jr.", 
    "state": "TN", 
    "thomas_id": "00322", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "pass", 
  "status_at": "1995-07-19T14:10:00-04:00", 
  "updated_at": "2013-07-17T07:50:48-04:00"
}